RVPH
Reviva Pharmaceuticals Holdings Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$2.47
-0.18 ▼ -6.79%
🌙 3월 13일 7:18 PM ET (한국 3/14 08:18)
$2.44
-0.03 ▼ -1.21%
| Index | - | P/E | - | EPS (ttm) | -9.17 | Insider Own | 4.3% | Shs Outstand | 0.01B | Perf Week | -30.85% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | 40.6% | Insider Trans | - | Shs Float | 0.01B | Perf Month | -53.15% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | -1.09 | Inst Own | 10.51% | Short Float | 18.04% | Perf Quarter | -83.08% |
| Income | -0.02B | P/S | - | EPS this Y | 62.86% | Inst Trans | 1.96% | Short Ratio | 3.89 | Perf Half Y | -72.13% |
| Sales | 0.00B | P/B | 2.62 | EPS next 5Y | 36.08% | ROA | -207.23% | Short Interest | 0.99M | Perf YTD | -55.73% |
| Book/sh | 0.94 | P/C | 1.08 | EPS past 3/5Y | -16.14% - | ROE | -916.17% | 52W High | -89.71% ($24.00) | Perf Year | -88.12% |
| Cash/sh | 2.29 | P/FCF | - | Sales past 3/5Y | - | ROIC | -500.18% | 52W Low | -3.52% ($2.56) | Perf 3Y | -97.19% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 58.55% | Gross Margin | - | Volatility(W/M) | 15.62% 10.59% | Perf 5Y | -98.54% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.47 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.39 | EPS Q/Q | 77.7% | Profit Margin | - | RSI (14) | 26.8 | Recom | 1.33 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.39 | Sales Q/Q | - | SMA20 | -40.3% ($4.14) | Beta | 0.34 | Target Price | $87.14 |
| Payout | - | Debt/Eq | 0 | Earnings | 11000000 | SMA50 | -54.13% ($5.38) | Rel Volume | 0.88 | Prev Close | $2.65 |
| Employees | 14 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 36.66% - | SMA200 | -73.52% ($9.33) | Avg Volume(3M) | 0.26M | Price | $2.47 |
| IPO | 2018/10/18 | Option/Short | Yes/Yes | Trades | 1596 | Volume | 225,742 | Change | -6.79% |
뉴스 로딩 중...